The overexpression of HER2/neu has been shown to be related to breast cell canceration (Dawood et al., 2010; de la Cruz-Merino et al., 2017), which suggests that it may be an anti-breast tumour target. The gene discussed is ERBB2; the disease is breast neoplasm.